ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

Part of paid clinical trials in Duarte, California.

Sponsor
Stanford University
Study ID
NCT02848274
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

The purpose of the study is to develop a prognostic index model for the rare disease of mycosis fungoides and sezary syndrome. This will be done by collecting standardized clinical data at various institutions. The investigators hope this will enable the identification of low- and high-risk groups for survival in order to improve patient care and outcome.

Key Dates

Start date
Oct 31, 2016
Status verified
Oct 2025
Primary completion
Mar 31, 2027
Completion
Mar 31, 2027

Study Design

Enrollment
2,000 participants (estimated)

Primary Outcome Measure

Overall survival (OS) [ Time Frame: date of diagnosis to death from any cause, up to two years ]

Central Contacts

Locations (7)

FacilityCityStateZIPSite coordinators
City of HopeDuarteCalifornia91010
Christiane Querfeld
[email protected]
Stanford University, School of MedicinePalo AltoCalifornia94305
Tatiana Neal
[email protected]
650-709-7838
Youn H Kim (PRINCIPAL_INVESTIGATOR)
University of IowaIowa CityIowa52242
Hackensack University Medical CenterHackensackNew Jersey07601
Tatyana Feldman, MD
[email protected]
University of PittsburgPittsburghPennsylvania15260
Oleg Akilov, MD
[email protected]
University of Texas SouthwesternDallasTexas75390
Heather Wickless
[email protected]
University of Utah HospitalSalt Lake CityUtah84132
David Wada, MD
[email protected]

Find similar trials in Duarte, CA

By research site
City of Hope· Duarte, CAStanford University, School of Medicine· Palo Alto, CAUniversity of Iowa· Iowa City, IAHackensack University Medical Center· Hackensack, NJUniversity of Pittsburg· Pittsburgh, PAUniversity of Texas Southwestern· Dallas, TX

Related Studies